Tag Archives: Research

Commitment to quality of care and patient safety takes the spotlight

Mamta Reddy, Vijay Babu Rayudu Endowed Chair of Patient Safety, with some of the 2022-23 QIPS Faculty Scholars Kevin O’Rourke, Valerica Mateescu, Kevin Gray, Majdi Hamarshi, Alicia Daggett and Geetha Kamath.

Betty Drees, M.D., was just a few years into her term as dean of the UMKC School of Medicine in 2007 when Vijay Babu Rayudu, one of her medical students, died unexpectedly.

“This was very much a life-changing event for many people,” Drees said, during the school’s 10th annual Vijay Babu Rayudu Quality and Patient Safety Day on May 5.

Today, the event Drees was instrumental in establishing highlights the school’s commitment to improving the quality of care and patient safety. Each year, medical students, residents and fellows present research conducted throughout the year focused on the topic of quality and patient safety.

During a morning session of the event, 49 poster presentations were made to a panels of judges that selected the top two student posters and the top two resident/fellow posters. Medical students Paige Eichhoff and Sydney Edson, resident Ramy Ghaly, M.D., and fellow Anna Nelson, M.D, received the top poster awards.

A record 58 abstracts were submitted on various topics related to the quality and patient safety, 36 of those from medical students. A panel of 30 judges also selected the top two student and top two resident/fellow presentations that were given as oral presentations during the afternoon session of the event. Medical students Madeline Glodowski and Mallika Joshi, resident Fouad Jaber, MD and fellow Edward Lyon, DO, received the top abstract awards.

Julie Banderas, right, receives the Faculty Mentor award from Betty Drees.

In addition, Julie Banderas, Pharm.D., assistant dean for graduate studies and allied health, was presented with a Faculty Mentor of the Year Award. Drees also received special recognition with a Quality and Patient Safety Lifetime Achievement Award.

Sanjay Saint, M.D., MPH, chief of medicine at the VA Ann Arbor Healthcare System and the George Dock Professor of Internal Medicine at the University of Michigan Saint, gave the day’s keynote address focused on implementing change to enhance patient safety.

“When I was in training, we would just tolerate those things that we couldn’t change,” he said. “Now, I think we’ve got an army of people out there who are going to change the things we can no longer tolerate.”

Patient safety, implementation science, and medical decision-making make up a large part of Saint’s research efforts. He has written nearly 350 peer-reviewed papers, more than 110 of those appearing in the New England Journal of Medicine, JAMA, The Lancet or the Annals of Internal Medicine. He is also a special correspondent to the New England Journal of Medicine and an elected member of the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP).

In 2011, members of the Rayudu family gave a gift of $500,000 to establish a Vijay Babu Rayudu Endowed Chair of Patient Safety. Mamta Reddy, M.D., currently serves the school in that role. Two years later, the School of Medicine conducted its first Vijay Babu Rayudu Quality and Patient Safety Day.

“To see what’s going on today makes me feel really proud to be here at UMKC,” Drees said.

To see a list of all the presentations given at this year’s event, go to the school’s Quality Improvement/Patient Safety page.

UMKC students put research efforts on display at Health Sciences Research Summit

Sayra Nieto Gomez, fifth-year medical student, presents her poster at the annual UMKC Health Sciences Student Research Summit.

The idea of seeking out a mentor and embarking on a research project was a somewhat frightening experience for Sayra Nieto Gomez when she got started.

But with the support of a program for students underrepresented in the health professions and a willing faculty mentor, the fifth-year UMKC School of Medicine student was one of nearly 70 students who presented a research project at the 2023 UMKC Health Sciences Student Research Summit.

The event took place on March 22 at the Children’s Mercy Kansas City Research Institute, returning the summit UMKC’s Health Sciences Campus after being held at the Student Union on the UMKC Volker Campus for the past several years.

The annual summit provides an avenue for health sciences students to display their research, while also fostering collaborations across disciplines and schools that will provide  economic, health, education and quality-of-life benefits for the community.

Students from the schools of medicine, pharmacy, dentistry, education, computing and engineering and psychological sciences presented posters that displayed a vast array of research on medical science topics to community health programs.

Faculty members from the health sciences schools judged and scored the presentations based on overall quality and aspects of the presentations, including the research hypothesis, background, methodology and conclusions. The top three scores were announced in three categories: overall, graduate students (residents, post-doc, fellows), and undergraduate students.

Nieto Gomez’s presentation placed second in the overall division. She worked with her mentor, Karl Kador, Ph.D., a scientist at the School of Medicine who focuses on retinal research, to produce an abstract that looked at how early stage retinal ganglion cells are formed.

“Hopefully we can take this information and one day apply it to find cures for blindness,” she said.

Medical student Josephine Nwankwo gave the top-scoring poster presentation at the UMKC Health Sciences Student Research Summit.

School of Medicine student Josephine Nwankwo had the top-scoring presentation in the overall division, while medical student Keerti Ivaturi had the top poster presentation in the undergraduate division and pharmacy resident Rachel Askew earned the top score in the graduate division.

Nieto Gomez is member of STAHR (Student Training in Academia, Health, and Research), a collaborative of the UMKC schools of medicine, dentistry and pharmacy designed to increase the number of students from disadvantaged backgrounds entering health care programs and better prepare them for success academically and professionally.

She said participating in the STAHR program and meeting with other underrepresented minority students provided her with the encouragement she needed to embark on a research project.

“The conversations we had in the STAHR program with other students, and hearing about how they were doing research and how they got involved helped,” she said. “It made me feel that if I can see other students in the program doing research, then I can do it.”

UMKC pharmacy resident Kristen Mize gives her poster presentation.

Kristen Mize, Pharm.D., a UMKC pharmacy resident who works with ambulatory care patients at a KC CARE Health Center clinic, was another student who presented a poster at the Research Summit. Hers described her efforts to provide early, preventive eye exams for patients with diabetes.

Mize explained how she is trained to perform simple eye exams using a retina imaging machine to look for early signs of diabetic retinopathy. Diabetic retinopathy is the leading cause of adult blindness and vision loss. It occurs when a diabetic’s blood sugar level rises too high, causing small blood vessels in the retina to break and leak blood or fluid into the eye, damaging the retina.

The project also looked at the effect her service has had on patients keeping current on eye exams.

“The purpose is to catch things early before the patient knows they have that issue,” Mize said of the exam.

Mize also planned to present her poster at a pharmacy conference later in the week with a broader message for pharmacists and other health care providers.

“For pharmacists, I want to show that we can do this,” she said. “I got trained on this machine and I’m the only person at KC CARE offering the exam right now. Next month I’m going to be training nurse practitioners, and they’ll be able to do it. Our message to those who aren’t ophthalmologists is, you can make a difference in this, too.”

2023 UMKC Health Sciences Student Research Summit
Top Scoring Posters and Presentations

  • 1st Place – Josephine Nwankwo, School of Medicine: Relationship between SES and Utilization of a Hospital Based Food Pantry
  • 2nd Place – Sayra Nieto Gomez, School of Medicine: Early Stage Retinal Ganglion Cells Have Increased Axon Growth
    Mentor: Dr. Karl Kador
  • 3rd Place – Vijay Dimri, Shruti Mishra, Mauli Patel, School of Medicine: Posterior Reversible Encephalopathy Syndrome in a Trauma Patient with Multiple Gunshot Wounds
    Mentor: Dr. Binod Wagle

Undergraduate Posters

  • 1st Place – Keerti Ivaturi, School of Medicine: Effects of Placenta Glucocorticoid Receptor Knockout on Gene Expression and Fetal Survival
    Mentor: Dr. Dave Bridges
  • 2nd Place – Samuel Brown, School of Medicine: Pericyte Recruitment and von Willebrand Factor Expression are Associated with Blood-Brain Barrier Tight Junction Formation During Embryonic Development in Mice
    Mentor: Dr. Nihar Nayak
  • 3rd Place – Paris Yates, School of Medicine: Is Ciclesonide a safer glucocorticoid alternative  in the developing brain for  preterm birth?
    Mentor: Dr. Paula Monaghan-Nichols

Graduate Posters

  • 1st Place – Rachel Askew, School of Pharmacy: Impact of pharmacist-led intervention of dispensing naloxone to an at risk of overdose patient population
    Mentor: Dr. Yifei Liu
  • 2nd Place – Dr. Soumya Rao, School of Dentistry:  Loss of Function Mutations in SF3B2, A Regulator of mRNA Splicing, as a Cause of Oculo-Auriculo-Vertebral Spectrum
    Mentor: Dr. Timothy Cox
  • 3rd Place – Roland Klar, School of Dentistry: 3D printed multi-gradient microsphere scaffolds for guided osteochondral tissue engineering
    Mentor: Dr. Stefan Lohfeld

UMKC Researcher Receives $2.2 Million NIH Grant to Explore Expanded COVID-19 Testing

Jannette Berkley-Patton, Ph.D., director of the UMKC Health Equity Institute and a professor in the Department of Biomedical and Health Informatics at the School of Medicine, has received a nearly $2.2 million, two-year grant from the National Institutes of Health for a project designed to increase testing and treatment for COVID-19 by partnering with African American churches and health agencies. 

The effort is part of an NIH initiative called Rapid Acceleration of Diagnostics-Underserved Populations (RADx-Up); a consortium of community-engaged research projects designed to increase access to COVID testing in underserved communities.  

The randomized trial will study the effectiveness of a religiously tailored intervention in motivating adult African American church and community members to be tested and to seek treatment for COVID-19.  

“We will work collaboratively with our churches to encourage people to not only get the rapid COVID test, but to get treatment that could potentially help reduce their symptoms and likely keep them out of the hospital.” – Jannette Berkley-Patton, Ph.D.

Working with 12 community churches in the Kansas City area, the program will engage the help of pastors to promote testing and demonstrate to their congregations how testing works. Among other services, the churches will also offer rapid COVID testing and provide support and referrals to treatment to those who test positive. 

“Our project will examine whether people really want to get tested and seek treatment if we use a religiously tailored approach,” Berkley-Patton said. “We will work collaboratively with our churches to encourage people to not only get the rapid COVID test, but to get treatment that could potentially help reduce their symptoms and likely keep them out of the hospital. 

“We’re hoping this approach can be informative not only for this study but for other types of rapid diagnostics that can lead to treatment, especially if the referral is made quickly and support is provided.”  

The new grant-funded study is a continuation of Berkley-Patton’s Faithful Response to COVID-19 project, a two-year, NIH-backed clinical trial that started in January 2021 to promote COVID-19 testing with the African American community with the support of churches and other faith-based and community organizations. 

Those efforts were so successful in testing and raising awareness that the Jackson County Legislature awarded a $5 million grant to support Our Healthy Kansas City Eastside, another UMKC Health Equity Institute project that administered nearly 13,000 COVID vaccinations to members of Kansas City’s minority and underrepresented communities in just 18 months. The county recently extended that program as well with the support of an additional $5 million grant. 

“In the early days of the pandemic, COVID testing was not available to everyone. Access to testing was particularly limited in underserved communities, which led to the NIH initiative RADxUP,” Berkley-Patton said. “In the initial project, we are demonstrating that people will take the test at a church site – and even more so when the efforts are religiously and culturally tailored.” 

The new study will examine the beliefs and practices of those in underserved communities toward rapid COVID-19 self-testing. Researchers also will study the effectiveness of contact tracing as well as care services such as referrals to treatment, health insurance and community resources. 

“With this model, many of our Faithful Response materials are packaged in an easy-to-use toolkit that our community partners helped to create, and can be disseminated in print or electronic formats,” Berkley-Patton said. “We’re hoping the toolkit can be widely disseminated across the country if we can show that the first Faithful Response project was effective and double that up with efficacy of the second project.”

The High Priest of Sound

Paul Rudy has always been fascinated with sound. He’s ridden the sound waves to many impressive achievements as a composer, performer, Guggenheim Fellow, Fulbright Fellow, artist and sound healer. He’s currently the Curator’s Distinguished Professor, but his path to UMKC and the honorary title “High Priest of Sound” was as winding as the labyrinth he created on his Kansas farm.

“I understood the power of sound when I was a kid,” Rudy recalled. “My sister was watching a horror movie, and I was behind the couch playing. I heard this sound, and I stood up and started watching. It totally sucked me in. That movie scared the crap out of me! But I knew it was that sounds that drew me in.”

Rudy’s fascination with sound continued into his college career, even when he thought it wouldn’t.

“I did a jazz trumpet degree at Bethel College in Newton, then I quit music altogether and became a mountain climber and carpenter for four or five years,” he said. “That wasn’t stimulating my brain enough, though. I’ve been chasing my tail my whole life.”

The chase would bring him back to music in the late 80’s, when he joined a composition class at Wichita State University. It was there that he composed a piece of music his instructor described as graduate work. Invigorated by this taste of success, he applied for a music composition program at the University of Colorado and earned an assistantship in the program.

“I discovered the studio, and I fell in love with actually making and sculpting sound,” Rudy reminisced. “That’s why I went the electronic route.”

“Paul is a scientist.When I think of people in the Conservatory, I think of creators, musicians and artists, but I never think of science. And yet, Paul’s brain thinks like a scientist. He comes up with scientific principles, questions for us to analyze, and then he’s really good at analyzing data and distilling it down to what we need to answer our questions.”
– Gary Sutkin, M.D., director, Surgical Innovations Laboratory

It was this interest in electroacoustic music that would provide him with another opportunity in his academic career. This time, at UMKC’s Health Sciences Campus, working in tandem with Dr. Gary Sutkin, professor of surgery and associate dean of women’s health at the UMKC School of Medicine. Together, the two are studying how sounds in the operating room can affect health outcomes for patients during surgery.

“Paul is a scientist,” said Sutkin of his colleague. “When I think of people in the Conservatory, I think of creators, musicians and artists, but I never think of science. And yet, Paul’s brain thinks like a scientist. He comes up with scientific principles, questions for us to analyze, and then he’s really good at analyzing data and distilling it down to what we need to answer our questions.”

“I think my study with electroacoustics and knowing how the brain processes sound brought me to the operating room study,” Rudy says. “Sound is vibrating on us, acting upon us all the time. Every time we hear sound it’s not just hitting our ears; it’s hitting our whole body. There was a part of me that was excited about offering something other than just the study of music. This seemed to be an opportunity to take that work into a deeper, more significant arena, and it’s still unfolding.”

“We’ve been studying it for about two or three years, and we’re going to study it for about another 20,” said Sutkin, only half-jokingly. “We’re not the first ones to measure the sound environment, but I think we are the first ones to really delve into what we call ‘speech communication interference,’ when someone says something, and the other person doesn’t hear them. There are so many machines that are making loud noises, multiple conversations going on. We’re measuring those interferences, then I think we can make recommendations.”

Those recommendations could one day save lives by changing the very nature of how operating rooms are built and managed. For now, the pair are happy with the success they’ve seen, having been published in one medical journal, with a second article currently under review.

Rudy considers research a part of his creative process, satisfying his analytical side so as not to hinder creative flow while making his art. “The brain is really good at cataloging and organizing things, but the spirit knows how to make the best use of it all.” That was the realization, Rudy says, when creating became fun. “I felt like I had all these resources starting to really work together and complement each other.”

Rudy’s creative spirit carries well beyond music. Settled on 70 acres, north of Lawrence, Kansas, you’ll find Harmony Farm, a home as interesting and eccentric as the man who lives there.

“It’s become a canvas, of sorts, that I photograph and that I use to make modern day ‘Nazca Lines,’” says Rudy, referring to massive and mysterious geoglyphs etched across Peru’s Nazca Desert. While Rudy openly admits to keeping a quiet social life outside of the farm, he’s ever eager to share his passions with students at UMKC.

“Over the last ten years, I’ve started to love teaching,” Rudy says. “It went from being part of the job to something I really look forward to doing. Part of what I love is staying in touch with young people.”

“Paul is one of the most generous people I know, and one of the most open thinkers,” said Andrew Granade, former interim dean of the Conservatory. “I’ve been on dissertation graduate committees with him many, many times with his students, and they all sound like themselves. He has a unique ability to listen to them, respond to them and help them grow into the artist they need to be.”

Rudy challenges his students to find fresh perspectives, and he does so with zest, teaching a general education course he calls the artist in society.

“I’ve had students tell me they’ve never seen a piece of art before, I’ve had students tell me they’ve never had a conversation with someone they disagreed with before,” Rudy says. “And I just love seeing what happens when they have those new experiences. Part of my job is mentoring them into those new experiences. I present them with some really uncomfortable stuff, sometimes purposefully, for them to learn how to witness what happens in them when things get uncomfortable.”

“Paul is very Socratic in his teaching style,” said Granade, “I imagine the first couple of weeks it’s a little bit uncomfortable for them, because any time you have your beliefs or thoughts challenged, it’s uncomfortable. But what he’s doing is basically saying this is the role of the artist, literally the role of the artist in society is to open up these dialogues.”

Rudy says he wants students to think about the ways they act and react. How do they navigate obstacles? How do they learn and grow?

It’s a practice he recently had to exercise himself. But through a painful experience, he says he’s found one of his proudest moments.

Rudy’s long-time friend, poet Jay Hopler was 51 years old when he lost his battle with cancer in June. The two had studied together at the American Academy of Rome in Italy.

“In 2017, Jay was thinking about a poem that would describe himself, and he asked me, ‘If I were a piece of music, what would I be?’” Rudy says the melody was instant. “I heard the music in my head. That doesn’t happen often. Most of the time, it’s hard work, but I knew exactly what Jay sounds like.”

Holding up a copy of still life, Hopler’s final published book of poetry, Rudy turned to the last page of the closing entry, where just a few bars of music were included with the poet’s words.

“It’s the second-to-last line, even,” he notes. “I don’t think anybody’s ever done that before. A little piece of music, describing this poet, is part of his obituary poem. I didn’t know that until I saw the final copy of the book. I’m actually considering making a whole piece in memoriam of him to celebrate his amazing words and amazing life.”

It’s there Rudy shows his spirit again. His spirit for life, healing and creation through sound, even when faced with the loss of a friend. It’s this unique mindset that has pushed him to find success time and time again, both personally and professionally.

“For me,” Rudy says, “the bottom line is, ‘Is what I’m doing interesting?’ If not, is it the thing I’m doing? Or the way I’m doing it?” Adding, “It’s usually the latter.”

It’s this ability to reshape his own perspective that’s given Rudy new love for everything he does.

“I think that’s when my academic career started to change. When I realized it’s not the responsibility of my job to give me fulfillment, that’s my responsibility to find fulfillment in what I’m doing. I love these interesting collaborations that I’m constantly on the lookout for. Teaching is one of those collaborations between me and the generation that’s going to rule the world someday. How cool is that?”

School of Medicine announces Student Research Summit winners

UMKC students presented 46 posters during the 2022 Health Sciences Student Research Summit.

The annual UMKC Health Sciences Student Research Summit returned to an in-person event on March 2 at the UMKC Student Union after two years as a virtual event. Students from the schools of medicine, pharmacy, dentistry, biological and chemical sciences, and computing and engineering presented 46 research posters.

Four students from the School of Medicine and one each from the School of Biological and Chemical Sciences and the School of Pharmacy received awards for their presentations.

In the undergraduate division, third-year medical students took the top two awards. Suman Manek won first place in poster presentations. Nikitha Damisetty placed second and second-year med student Cooper Bassham placed third.

Fifth-year medical student Joseph Bean placed first in the graduate division. Jon Bell, from the School of Biological and Chemical Sciences was second, and sixth-year medical student Nicholas Yeisley placed third with his presentation.

A panel of faculty judges selected the top presentations.

The summit promotes collaborations across disciplines and schools to produce economic, health, education and quality of life benefits for the Kansas City community in a forum that brings the UMKC health sciences community together to highlight student research.

2022 UMKC Health Sciences Student Research Summit

Top Scoring Posters and Presentations

1st Place – Suman Manek BA/MD Student: Multivariate Prognostic Biomarkers of Covid-19: The Relationship Between Patient Demographics and Presenting Signs and Symptoms.
Mentor: Dr Wail Hassan, School of Medicine

2nd Place – Nikitha Damisetty, BA/MD Student: Modulating Glucocorticoid Function In-Utero to Reduce Complications of Pre-Term Birth.
Mentor: Dr. Paula Monaghan-Nichols, School of Medicine

3rd Place – Cooper Bassham, BA/MD Student: Glucocorticoid and Cannabinoid Signaling Interactions: Implications for Neural Stem Cells.
Mentor: Dr. Paula Monaghan-Nichols, School of Medicine

Winners by Category

Undergraduate Posters

1st Place – Suman Manek BA/MD Student: Multivariate Prognostic Biomarkers of Covid-19: The Relationship Between Patient Demographics and Presenting Signs and Symptoms.
Mentor: Dr Wail Hassan, School of Medicine

2nd Place – Nikitha Damisetti, BA/MD Student: Modulating Glucocorticoid Function In-Utero to Reduce Complications of Pre-Term Birth.
Mentor: Dr. Paula Monaghan-Nichols, School of Medicine

3rd Place – Cooper Bassham, BA/MD Student: Glucocorticoid and Cannabinoid Signaling Interactions: Implications for Neural Stem Cells.
Mentor: Dr. Paula Monaghan-Nichols, School of Medicine

Graduate Posters

1st Place – Joseph Bean, BA/MD Student: Active Targeting of Glioblastoma Through Phage Display.
Mentor: Dr. Kun Cheng, School of Pharmacy

2nd Place – Jon Bell, PhD Student: Foxg1a is Required for Hair Cell Development and Regeneration in the Zebrafish Lateral Line.
Mentor: Dr. Hilary McGraw, School of Biological and Chemical Sciences

3rd Place – Nicholas Yeisley, MD Student: Characterizing Social Determinants of Health of TMC ED Patients with Chronic Disease.
Mentor: Dr. Stephanie Ellison, School of Medicine, University Health

UMKC professors study the impact of sound on operating room safety

Faculty donation leads to collaboration between professors in the School of Medicine and UMKC Conservatory to yield safer surgeries

Medicine and music aren’t an obvious pair, but in a discussion between colleagues at the UMKC Surgical Innovations Lab, experts in each field realized an interesting link between the two topics.

Gary Sutkin, M.D., professor of surgery and associate dean of women’s health at UMKC, has focused much of his research on surgical safety and mitigating errors in the operating room. Today he’s working to expand that research by teaming up with his colleague – and composer – Paul Rudy, MM, DMA, Curators’ Distinguished Professor and coordinator of composition at the UMKC Conservatory, to study the effects of sound on patient safety in the operating room.

Studies have shown that reducing hospital noise levels has a direct impact on improving patient safety, but in operating rooms, in addition to conversations among the surgical team, the equipment required for surgeries makes noise. Though some sounds are necessary ­– such as the noise of the oxygen saturation monitor, which creates the rapid high-pitched beep people may recognize from medical shows on television — the noise created by people in the room often is not.

Gary Sutkin, M.D.

Rudy and Sutkin are working together to develop training and surgical methods that reduce some of the noise and related risk.

“People have been trying to solve the problem of miscommunication in the operating room for 20 years and there hasn’t been any meaningful progress,” Sutkin says. “What I know is that we need brains other than those of researchers, surgeons and nurses to study the problem.”

Sutkin’s interest in collaborating with people who have expertise in areas outside of medicine, coupled with Rudy’s curiosity and ability to hear the operating room with fresh ears is already leading to interesting results.

By observing surgeries, Rudy recognized that surgeons’ work entails very fine motor movements and unwavering focus that requires them to keep their heads down. He also observed other members of the surgical team are focused on their own tasks and responsibilities.

“People have been trying to solve the problem of miscommunication and errors in the operating for 20 years and there hasn’t been meaningful progress. What I know is that I need other brains than only researchers, surgeons and nurses.”
 Gary Sutkin, M.D.

“No one’s looking at the surgeon’s body language to figure out what’s needed,” Rudy says. “For example, the anesthesiologist is reading a screen. Much of the communication [the team receives] is coming through sound.”

But despite the importance of verbal communication, he observed a lot of the noise people make in the operating room is not critical to the surgery.

“Everyone is doing something necessary,” Rudy says. “But sometimes someone has to unpackage something in a hurry, and they can’t throw it in the trash can, so it ends up on the floor. Or someone picks up that big wad of plastic to get it out of the way and you can’t hear anything else over the noise. This has to be done – someone could trip over it – but if the surgeon needs to communicate something important to the anesthesiologist at that moment, the noise will mask the communication.”

Because of Rudy’s background as a musician, the amount of residual noise in the operating room came as a surprise.

“In rehearsals and in performances, no one makes any extra sound anywhere for any reason,” Rudy says. “Musicians carefully turn pages of sheet music so that the binder doesn’t make any noise.”

He’s aware of the differences between the disciplines, but still notes there is room for improvement when it comes to eliminating some unnecessary noise in operating rooms. Rudy’s research has identified solutions to common disruptions that OR teams may not even notice.

“For example, in the operating room there are really heavy metal step stools,” Rudy says. “People tend to scoot them across the floor with their feet and it makes this really intense grating sound that may mask any kind of communication that is going on in the room.”

Paul Rudy, Ph.D.

Rudy understands that the medical professionals in the operating room move the stools with their feet because they need to keep their hands sterile, but he wonders if manufacturers are aware of the ramifications of production decisions.

“This research could lead to that awareness, and maybe even influence manufacturing standards.”

Observations like this that lead to opportunity for innovation and increased safety is at the heart of the mission of Surgilab and are why Sutkin wants colleagues like Rudy in the operating room.

“There’s value in having insight from brains other than researchers, surgeons and nurses. Paul brings a wealth of knowledge and creativity. And, surprisingly, to be honest, a scientific mind that contributes very well with this research.”

A gift from UMKC professor emerita, Elizabeth Noble, Ph.D., helped fund this research collaboration. Noble supports research that reaches across different fields of study because she thinks it makes the outcomes more reliable and more transferable.

“Today most researchers would agree that cross-disciplinary research is valuable,” Noble says. “It stimulates new ways of thinking about different issues, especially when we’re talking about music and medicine which are not always assumed to go together.”

“This research is exactly what I hoped would occur. I’m very happy that Dr. Rudy has had this kind of success,” she added.

Mario Castro, M.D., ’88, cares for patients on a global level

Alumni Reflections Through 50 Years
Mario Castro, M.D., ’88, and his family

Since 1971, nearly 4,000 physicians and health care professionals across the United States have received their degrees from the UMKC School of Medicine. As a leadup to our Gold Jubilee 50th anniversary event on June 4, we will spotlight some of our alumni who embody the school’s spirit and excellence in medical education and patient care.

Today, we catch up with Mario Castro, M.D., ’88, a pulmonary care specialist who received the 2021 E. Grey Dimond Take Wing Award.

Where are you now and where are you working?

I’m now live in Lenexa, Kansas. I joined the University of Kansas School of Medicine in 2019 and serve as L. E. Phillips and Lenora Carr Phillips Professor, chief of pulmonary, critical care and sleep medicine. I am also vice chair for clinical and translational research and director of the Frontiers Clinical and Translational Science Institute.

What is your focus?

Asthma and COPD have been my focus at KUMC. When I’m not working, I focus on my family, running and biking.

While working on improving respiratory health throughout the developing world, Castro also played a major role in the battle against COVID-19 on a global level. He worked with partners throughout Kansas City on one of the largest vaccine studies in the country to develop a global vaccine that could be taken to the farthest reaches of the world. The study enrolled more than 500 participants in Kansas City who were part of an effort that resulted in the development of the COVID vaccine most used worldwide.

Can you share something that people may not know about you?

I came to the U.S. as a refugee from Cuba as a young child. In one of my efforts to give to those in need, I am a board member of the International Medical Assistance Foundation (IMAF), an organization that reaches the underserved in Honduras and lead an annual medical brigade to Hospital Hermano Pedro in Catacamas, Honduras.

Castro oversees a board that regularly sends volunteer teams of ENT, orthopedics, cardiology, neurology and other specialists to remote areas of Honduras. Twelve years ago, the Honduran government provided $3 million and the IMAF raised another $3 million through church donations and fundraisers to build and supply the 100-bed Hospital Hermano Pedro. Just prior to the onset of the COVID pandemic, Castro and his team saw and treated 1,300 pulmonary patients in less than a week at the hospital.

 

 

School of Medicine’s Peter Koulen honored for achievements, advocacy in vision research

Koulen, Peter
Peter Koulen, Ph.D.

The Association for Research in Vision and Ophthalmology (ARVO) has recognized Peter Koulen, Ph.D., director of basic research at the UMKC School of Medicine’s Vision Research Center, with a major honor, its 2021 Achievements in Eye and Vision Advocacy Award.

ARVO is the largest eye and vision research organization in the world. As part of its annual Advocacy Awards, the Achievements in Eye and Vision Advocacy Award recognizes members who have dedicated the core of their careers to advancing eye and vision research.

Koulen, a professor of ophthalmology and biomedical sciences, is the School of Medicine’s Felix and Carmen Sabates Missouri Endowed Chair in Vision Research. He is an internationally recognized expert in biophysics, biochemistry and physiology of nerve cells with more than 50 extramural grants totaling more than $15 million. His focus on the retina as part of the central nervous system has resulted in peer-reviewed publications in more than 100 prestigious journals. He has also received three patents.

Koulen said the award from ARVO is an “amazing honor” that underscores the importance of his research efforts.

“The many opportunities ARVO has afforded me during my professional career taught me early on that service and giving back are not just integral to research, but are the key ingredients to growing research programs and maximizing their impact,” he said. “The award will also serve as a constant reminder to me that the important work of advocating and providing outreach opportunities for eye and vision research is never done.”

Koulen is a review panel member for national and international funding agencies including the U.S. Department of Defense, the National Science Foundation (NSF), and the National Institutes of Health. While chair of ARVO’s Advocacy and Outreach Committee, Koulen participated in Advocacy Day on Capitol Hill to discuss the importance of increasing funding for the NIH and the National Eye Institute.

This is the latest major award Koulen has received for his research at UMKC. The university Board of Trustees also honored Koulen in 2020 with its Trustees’ Faculty Fellow Award given to an established faculty member for a nationally and internationally recognized record of research and creative achievements at UMKC.

SOM researcher receives NIH grant to study treatment for chronic lung disease

UMKC School of Medicine researcher Paula Monaghan Nichols, Ph.D., has received a $867,000 National Institutes of Health grant to look into a treatment that minimizes neurological side effects for a chronic lung disease that affects a significant number of premature babies.

The project is part of a multi-principle investigator initiated proposal between Monaghan Nichols, Dr. Venkatesh Sampath from Children’s Mercy Hospital Kansas City, and Dr. Donald DeFranco at the University of Pittsburgh School of Medicine, Pennsylvania, that totals more than $3 million in NIH funding over a 5-year period.

The research will explore the use of Ciclesonide (CIC), an inhaled steroid currently used to treat asthma, as an alternate therapy for bronchopulmonary dysplasia (BPD). BDP causes tissue damage in the tiny air sacs of the lung leading to severe respiratory distress. It is often the result premature birth and mechanical oxygen ventilation. The disease touches nearly seven of 10 infants born before 28 weeks of gestation. In the United States, that is an estimated 10,000 to 15,000 babies a year.

There is currently no cure for BPD but clinical treatments to limit inflammation and the progression of BPD include long-acting synthetic drugs such as dexamethasone. Those drugs, however, also come with a significant risk of adverse effects on a child’s systemic growth and neurodevelopment that can lead to long-lasting changes in brain structure and function.

Monaghan Nichols, associate dean for research, professor and chair of Biomedical Sciences, said infants that acquire BPD face significant mortality rates. Survivors often have recurrent hospital visits, need for respiratory therapies and persistent limitations in pulmonary function.

“Therefore, there remains a need for a pharmacotherapy for BPD in neonates that will have beneficial anti-inflammatory and lung maturation effects, but limited adverse neurological side effects,” Monaghan Nichols said.

Preliminary studies have found that Ciclesonide, even with intermittent doses, can suppress acute lung inflammation with limited neurological alterations in rat models.

“Given the established safety of CIC in very young children, the clinical translation of our proposed studies to human neonates could be expedited, particularly given the limited, safe and effective therapeutic options available for treating or preventing BPD in susceptible premature infants,” Monaghan Nichols said.

SOM researcher receives NIH grant to study treatment for chronic lung disease

Monaghan-Nichols, Paula
Paula Monaghan-Nichols, Ph.D.

UMKC School of Medicine researcher Paula Monaghan Nichols, Ph.D., has received a $867,000 National Institutes of Health grant to look into a treatment that minimizes neurological side effects for a chronic lung disease that affects a significant number of premature babies.

The project is part of a multi-principle investigator initiated proposal between Dr. Monaghan Nichols, Dr Venkatesh Sampath from Children’s Mercy Hospital Kansas City, and Dr. Donald DeFranco at the University of Pittsburgh School of Medicine, Pennsylvania, that totals more than $3 million in NIH funding over a 5-year period.

The research will explore the use of Ciclesonide (CIC), an inhaled steroid currently used to treat asthma, as an alternate therapy for bronchopulmonary dysplasia (BPD). BDP causes tissue damage in the tiny air sacs of the lung leading to severe respiratory distress. It is often the result premature birth and mechanical oxygen ventilation. The disease touches nearly seven of 10 infants born before 28 weeks of gestation. In the United States, that is an estimated 10,000 to 15,000 babies a year.

There is currently no cure for BPD but clinical treatments to limit inflammation and the progression of BPD include long-acting synthetic drugs such as dexamethasone. Those drugs, however, also come with a significant risk of adverse effects on a child’s systemic growth and neurodevelopment that can lead to long-lasting changes in brain structure and function.

Monaghan Nichols, associate dean for research, professor and chair of Biomedical Sciences, said infants that acquire BPD face significant mortality rates. Survivors often have recurrent hospital visits, need respiratory therapies and experience persistent limitations in pulmonary function.

“Therefore, there remains a need for a pharmacotherapy for BPD in neonates that will have beneficial anti-inflammatory and lung maturation effects, but limited adverse neurological side effects,” Monaghan Nichols said.

Preliminary studies have found that Ciclesonide, even with intermittent doses, can suppress acute lung inflammation with limited neurological alterations in rat models.

“Given the established safety of CIC in very young children, the clinical translation of our proposed studies to human neonates could be expedited, particularly given the limited, safe and effective therapeutic options available for treating or preventing BPD in susceptible premature infants,” Monaghan Nichols said.